Midven led the seed financing round to support team expansion and product development.
"This investment marks a significant step forward for D-RisQ, enabling us to form a valuable partnership with Midven and the MEIF. The additional finance will accelerate the Company’s growth and provide access to additional business expertise, enabling the transition from a research and development company to a major supplier of automated software development tools."
Angel Academe led the seed investment in the cyber-security platform.
"For such an early stage business, Eva and the Bewica team were extremely well-organised and ready for investment. With the drastic increase in virtual working and business conducted online, cyber fitness is a major and growing concern for SMEs, so the timing felt right. Also, Bewica was developed in partnership with customers such as banks and insurance providers as a direct response to the growing threat of cyber crime for their own clients, so the product-market fit was another strong reason to invest. We’re excited to see what the future holds for Bewica and happy to be counted among their early supporters."
Fortunis Capital backed the female-led mental wellbeing app to accelerate its growth and service expansion.
"We have huge growth plans – we are the only mental wellbeing app that really, really understands what women need when it comes to their mental wellbeing. In a space where the leading apps are all lead by men it’s time to shake this up."
Techstart Ventures led the round with backing from Active Capital and Ankur Nagpal.
"Online summits have been a tool for digital marketers to share knowledge, but it’s always been complicated and cost-prohibitive for most entrepreneurs,"
The Reading-based healthcare technology company secured the financing over five months to progress product development and clinical trials.
"Healthcare is one of the areas of biggest interest to our investor database. In the year of a global pandemic this is perhaps no surprise – but this business really did tick all the boxes for our investors. They have patent-protected IP with a product developed by a team with extensive medical experience. They also have a track record of high value medical and technology exits. We look forward to seeing the development of this business and its potential ability to improve the lives of millions of people."
— Ed Stephens, Global Head of Brokerage and Partnerships